Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07829952) titled 'Efficacy and Safety of Romiplostim N01 for Injection in Promoting Platelet Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation' on Sept. 11.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: The First Affiliated Hospital of Henan University of Science and Technology
Condition:
Thrombocytopenia
Allogeneic Hematopoietic Stem Cell Transplantation
Intervention:
Drug: Romiplostim N01
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: Novem...